Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
Qian-Qian Chen, Caroline Haikal, Wen Li, et al.
Frontiers in Molecular Neuroscience (2019) Vol. 12
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications
Sonia Facchin, Luisa Bertin, Erica Bonazzi, et al.
Life (2024) Vol. 14, Iss. 5, pp. 559-559
Open Access | Times Cited: 51
Polyamines in Parkinson's Disease: Balancing Between Neurotoxicity and Neuroprotection
Stephanie Vrijsen, Marine Houdou, Ana Cascalho, et al.
Annual Review of Biochemistry (2023) Vol. 92, Iss. 1, pp. 435-464
Open Access | Times Cited: 41
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
Bang-rong Wei, Yujia Zhao, Yufeng Cheng, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020
Kevin McFarthing, Sue Buff, Gary Rafaloff, et al.
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 3, pp. 757-774
Open Access | Times Cited: 120
The Gut-Brain Axis: Two Ways Signaling in Parkinson’s Disease
Nitu Dogra, Ruchi Jakhmola Mani, Deepshikha Pande Katare
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 2, pp. 315-332
Closed Access | Times Cited: 85
Neurodegenerative disorders and gut-brain interactions
Alpana Singh, Ted M. Dawson, Subhash Kulkarni
Journal of Clinical Investigation (2021) Vol. 131, Iss. 13
Open Access | Times Cited: 83
T Lymphocytes in Parkinson’s Disease
Elena Contaldi, Luca Magistrelli, Cristoforo Comi
Journal of Parkinson s Disease (2022) Vol. 12, Iss. s1, pp. S65-S74
Open Access | Times Cited: 46
The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice
Timur Zanikov, Marta Gerasymchuk, Esmaeel Ghasemi Gojani, et al.
Molecules (2023) Vol. 28, Iss. 6, pp. 2624-2624
Open Access | Times Cited: 28
Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a mouse model of alpha-synucleinopathy
Lucia Rota, Carolina Pellegrini, Laura Benvenuti, et al.
Translational Neurodegeneration (2019) Vol. 8, Iss. 1
Open Access | Times Cited: 71
Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model
Xiao‐Li Dong, Xiong Wang, Fang Liu, et al.
International Journal of Biological Macromolecules (2020) Vol. 164, pp. 994-1005
Closed Access | Times Cited: 56
Loliolide, a New Therapeutic Option for Neurological Diseases? In Vitro Neuroprotective and Anti-Inflammatory Activities of a Monoterpenoid Lactone Isolated from Codium tomentosum
Joana Silva, Celso Alves, Alice Martins, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1888-1888
Open Access | Times Cited: 55
Altered Actinobacteria and Firmicutes Phylum Associated Epitopes in Patients With Parkinson’s Disease
Zhuo Li, Gang Lü, Zhe Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 46
Caprylic acid ameliorates rotenone induced inflammation and oxidative stress in the gut-brain axis in Zebrafish
Derya Cansız, İsmail Ünal, Ünsal Veli Üstündağ, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 6, pp. 5259-5273
Closed Access | Times Cited: 45
Mild Chronic Colitis Triggers Parkinsonism in LRRK2 Mutant Mice Through Activating TNF‐α Pathway
Chin‐Hsien Lin, Han‐Yi Lin, En‐Pong Ho, et al.
Movement Disorders (2021) Vol. 37, Iss. 4, pp. 745-757
Closed Access | Times Cited: 42
The Crosstalk between Microbiome and Mitochondrial Homeostasis in Neurodegeneration
Fivos Borbolis, Eirini Mytilinaiou, Konstantinos Palikaras
Cells (2023) Vol. 12, Iss. 3, pp. 429-429
Open Access | Times Cited: 18
α-Synuclein disrupts the anti-inflammatory role of Drd2 via interfering β-arrestin2-TAB1 interaction in astrocytes
Ren‐Hong Du, Yan Zhou, Meiling Xia, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 47
Gut Microbiota Approach—A New Strategy to Treat Parkinson’s Disease
Jing Liu, Fei Xu, Zhiyan Nie, et al.
Frontiers in Cellular and Infection Microbiology (2020) Vol. 10
Open Access | Times Cited: 40
The Link between Gut Dysbiosis Caused by a High-Fat Diet and Hearing Loss
Dagmara Kociszewska, Jeffrey Chan, Peter R. Thorne, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13177-13177
Open Access | Times Cited: 34
Cholecystokinin and glucagon-like peptide-1 analogues regulate intestinal tight junction, inflammation, dopaminergic neurons and α-synuclein accumulation in the colon of two Parkinson's disease mouse models
Yunfang Su, Ningning Liu, Zijuan Zhang, et al.
European Journal of Pharmacology (2022) Vol. 926, pp. 175029-175029
Closed Access | Times Cited: 24
Neuroprotective effects of an engineered Escherichia coli Nissle 1917 on Parkinson's disease in mice by delivering GLP ‐1 and modulating gut microbiota
Heng Wu, Jing Wei, Xiumiao Zhao, et al.
Bioengineering & Translational Medicine (2022) Vol. 8, Iss. 5
Open Access | Times Cited: 23
Towards early detection of neurodegenerative diseases: A gut feeling
Stephanie Makdissi, Brendon D. Parsons, Francesca Di Cara
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 14
Modulating α-synuclein propagation and decomposition: Implications in Parkinson's disease therapy
Beining Li, Xue Xiao, Mingxia Bi, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102319-102319
Closed Access | Times Cited: 5
The Underlying Mechanism of Paeonia lactiflora Pall. in Parkinson’s Disease Based on a Network Pharmacology Approach
Wan-Qing Du, Xiao Liang, Shanze Wang, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 36
Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
Yimin Yang, Yanhua Li, Hongmei Yang, et al.
Frontiers in Molecular Neuroscience (2021) Vol. 14
Open Access | Times Cited: 27
The link between increased Desulfovibrio and disease severity in Parkinson’s disease
Shiqing Nie, Zhongwang Jing, Jichen Wang, et al.
Applied Microbiology and Biotechnology (2023) Vol. 107, Iss. 9, pp. 3033-3045
Closed Access | Times Cited: 12
Page 1 - Next Page

Scroll to top